Phased affinity-controlled delivery of vascular endothelial growth factor, fibroblast growth factor-2, and platelet derived growth factor enhances in vitro angiogenesis
Justin E. Svendsen, Chandler L. Asnes, Samuel R. Nightheart, Madeleine R. Ford, Athena Hajarizadeh, Sang Cheul Oh, Henry B. Hochstatter, Johnathan R. O’Hara-Smith, Robert E. Guldberg, Marian H. Hettiaratchi
This study develops affibody-conjugated hydrogels to phase the delivery of VEGF, FGF-2, and PDGF, enhancing in vitro angiogenesis by 2.8-fold in vascular network length and 4.1-fold in branching.
Journal of Controlled Release · Jul 14, 2026Peer-reviewedBioengineering